With an estimated 1.5 million new cases and 397,000 deaths worldwide, prostate cancer is the world's second most frequent ...

Effect of inhibition of receptor tyrosine kinase AXL by a selective small molecular inhibitor R428 (BGB321) on DNA damage repair response in ovarian cancer cells. Ruby Yun-Ju Huang, Xun Hui Yeo, Wai ...

Researchers have found in a new research that SGLT2 inhibitors may provide dual benefits in treating both diabetes and fatty ...

Discover a study uncovering how JAK inhibitors protect against autoimmune diabetes triggered by cancer immunotherapy.

Immune checkpoint inhibitors have changed the future of cancer care. These powerful treatments use the body’s own immune ...

Nausea and, to a lesser extent, vomiting are among the most common adverse effects associated with all the three FDA-approved PARP inhibitors (olaparib, niraparib, and rucaparib) in patients with ...

Toll-like receptor 3 (TLR3) has been noted to impact liver disease and promote liver inflammation. Researchers from Southern Medical University screened a natural product molecular library and found ...

The inhibitory effects lead to increased sodium and urine excreted, reduced resistance in kidney blood vessels, increased venous capacity, and decreased cardiac output, stroke work, and volume.

Cite this: JAK Inhibitor Effects in RA Confirmed inReal-World Study - Medscape - Nov 02, 2023. Authors and Disclosures. Authors and Disclosures Journalist Heidi Splete. Comments ...

MEK1 or mitogen-activated protein kinase kinase 1 (rabbit) protein. MEK inhibitors are used in treatment of cancer and include cobimetinib and trametinib. 3D rendering from pdb entry 5kkr.